Loading candles…
Ortin Global Ltd., initially incorporated in 1986 as Ortin Laboratories Ltd, underwent rebranding to its current name around late 2024 to early 2025. The company operates primarily in the pharmaceutical and healthcare industries within India. It is engaged in manufacturing and trading pharmaceutical products, including pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs), and intermediate formulations. Its product range covers therapeutic segments such as anti-diabetics, anti-retrovirals, and anti-pyretics. Ortin Global Ltd. focuses on serving the pharmaceutical and healthcare sector in India. No information about founders, key management, subsidiaries, notable projects, or stock exchange listings is available.
This page is a live market overview for ORTIN GLOBAL LIMITED (ORTINGLOBE) on the NSE. As a listed security, ORTIN GLOBAL LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ORTINGLOBE before placing trades on tick2trade.
As of the latest feed, ORTINGLOBE last traded at ₹15.19 on NSE, up ₹0.45 (3.05%) from the previous close of ₹14.74. Today's session range is ₹14.7 – ₹15.19, against a 52-week band of ₹10.66 – ₹21.3. Traded volume today stands at 7.05K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for ORTINGLOBE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ORTINGLOBE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ORTIN GLOBAL LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ORTINGLOBE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ORTINGLOBE option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | 14 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and other business matters | 30 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 14 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 and other business matters | 14 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 14 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 26 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.